Two human stromal cell lines were established previously from bone marrow-derived primary long-term cultures by immortalization using the SV40 large T antigen and cellular cloning. After irradiation, the fibroblast-like cell lines L87/4 and L88/5 support hematopoietic differentiation of allogeneic cord blood cells in vitro. The stromal cells do not express CD34 and CD50, but some adhesion molecules and integrins, such as CD44, CD54 and CD58. Their expression profiles on RNA and protein levels are suggestive of their osteogenic potency. The quality and quantity of osteocalcin and osteopontin protein expression depended on the culture conditions. Expression of the osteogenic markers increased over time in culture, especially in cells growing in clusters. The stromal cells also expressed collagens I and V, but did not show any expression of collagens II and III. The potentially osteoblastic stromal cells were transplanted into NOD/ SCID recipient mice by intravenous injection and were found in various mesenchymal organs up to 10 weeks after transplantation. Osteocalcin-positive human stromal cells could be detected in the bone marrow, thymus, liver, brain and gut of the recipient animals. In summary, there is evidence that human bone-marrow-derived stromal cells have to be considered mesenchymal progenitors, persistently expressing osteogenic markers in vitro and in vivo.

1.
Deans RJ, Mosley AB: Mesenchymal stem cells: Biology and potential clinical uses. Exp Hematol 2000;28:875–884.
2.
Majors AK, Boehm CA, Nitto H, Midura RJ, Muschler GF: Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J Orthopaed Res 1997;15:546–557.
3.
Huss R, Hong DS, McSweeney PA, Hoy CA, Deeg HJ: Differentiation of canine marrow cells with hematopoietic characteristics from an adherent stromal cell precursor. Proc Natl Acad Sci USA 1995;92:748–752.
4.
Huss R, Hoy CA, Deeg HJ: Stroma derived hematopoietic progenitors: Cell cycle dependent proliferation and differentiation; in Gluckman E, Coulombel E (eds): Ontogeny of Hematopoiesis. Aplastic Anemia. Colloque Inserm. Paris, Libbey Eurotext,1995, vol 235, pp 209–213.
5.
Huang S, Terstappen LWMM: Formation of hematopoietic microenvironment and hematopoietic stem cells from single human bone marrow stem cells. Nature 1992;360:745–748.
6.
Huang S, Terstappen LWMM: Formation of hematopoietic microenvironment and hematopoietic stem cells from single human bone marrow stem cells (correction). Nature 1994;368:364.
7.
Thalmeier K, Meissner P, Reisbach G, Hültner L, Mortenson BT, Brechtel A, Oostendorp RAJ, Dörmer P: Constitutive and modulated cytokine expression in two permanent human bone marrow stromal cell line. Exp Hematol 1996;24:1–9.
8.
Thalmeier K, Meissner P, Reisbach G, Fak M, Brechtel A, Dörmer P: Establishment of two permanent bone marrow stromal cell lines with long-term post-irradiation feeder capacity. Blood 1994;83:1799–1807.
9.
Gronthos S, Graves SE, Ohta S, Simmons PJ: The STRO-1+ fraction of adult bone marrow contains osteogenic precursors. Blood 1994;84:4164–4173.
10.
Lajeunesse D, Kiebzak GM, Frondoza C, Sacktor B: Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG-63. Bone Miner 1991;14:237–250.
11.
Morike M, Schulz M, Brenner RE, Bushart GB, Teller WM, Vetter U: In vitro expression of osteoblastic markers in cells isolated from normal fetal and postnatal human bone and from bone of patients with osteogenesis imperfecta. J Cell Physiol 1993;157:439–444.
12.
Bidwell JP, Alvarez M, Feister H, Onyia J, Hock J: Nuclear matrix proteins and osteoblast gene expression. J. Bone Miner Res 1998;13:155–167.
13.
Chesney J, Bacher M, Bender A, Bacula R: The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Aacd Sci USA 1997;94:6307–6312.
14.
Prockop DJ: Marrow stromal cells as stem cells for nonhematopoietic tissue. Science 1997;276:7174.
15.
Huss R, Lange C, Weissinger EM, Kolb HJ, Thalmeier K: Evidence of peripheral blood-derived, plastic adherent CD34–/low hematopoietic stem cell clones with mesenchymal stem cell characteristics. Stem Cells 2000;18:252–260.
16.
Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, et al: Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998;279:1528–1532.
17.
Huss R, Günther W, Schumm M, Ottinger H, Grosse-Wilde H, Kolb HJ: CD34-negative hematopoietic stem cells isolated from human peripheral blood cells as ultimate precursors of hematopoietic progenitors. Infusionsther Transfusionsmed 1997;24:404–409.
18.
Lange C, Kaltz C, Thalmeier K, Kolb HJ, Huss R: Hematopoietic reconstitution of syngeneic mice with a peripheral blood-derived, monoclonal CD34, Sca-1+, Thy-1low, c-kit+ stem cell line. J Hematother 1999;8:335–342.
19.
Osawa M, Hanada K, Nakauchi H: Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996;273:242–245.
20.
Zanjani ED, Almeida-Porada G, Livingston AG, Flake AW, Ogawa M: Human bone marrow CD34-negative cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. Exp Hematol 1998;26:353–358.
21.
Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE: A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med 1998;9:1038–1045.
22.
Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC: Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996;183:1797–1806.
23.
Simmons PJ, Torok-Storb B: CD34 expression by stromal precursors in normal human adult bone marrow. Blood 1991;78:2848–2853.
24.
Huss R: CD34-negative stem cells as the earliest precursors of hematopoietic progeny. Exp Hematol 1998;26:1022–1023.
25.
Horwitz, E.M. Prockop DJ, Fitzpatrick LA, Koo WWK, Gordon PL, Neel M, SussmanM, Orchard P, Marx JC, Pyeritz RE, Brenner MK: Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999;5:309–313.
26.
Huss R, Hoy CA, Deeg HJ: Contact and growth factor involved in proliferation and differentiation in a canine marrow-derived stromal cell line. Blood 1995;85:2414–2421.
27.
Huss R, Gatsios P, Graeve L, Lange C, Eissner G, Kolb HJ, Thalmeier K, Heinrich PC: Quiescence of CD34-negative hematopoietic stem cells is mediated by downregulation of cyclin B and no STAT activation. Cytokine 2000;121195–1204.
28.
Singer JW, Keating A, Cuttner J, Gown AM, Jacobson R, Killen PD, Moohr JW, Najfeld V, Powell J, Sanders J, Striker GE, Fialkow PF: Evidence for a stem cell common to hematopoiesis and its in vitro microenvironment: Studies of patients with clonal hematopoietic neoplasia. Leuk Res 1984;8:535–539.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.